Piper Sandler resumed coverage on Neoleukin Therapeutics with a new price target

8/6/21 7:21:14 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Piper Sandler resumed coverage of Neoleukin Therapeutics with a rating of Overweight and set a new price target of $30.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NLTX

Date	Price Target	Rating	Analyst
3/2/2022	$30.00 → $25.00	Overweight	Piper Sandler
8/6/2021	$30.00	Overweight	Piper Sandler